Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/1999
11/18/1999WO1999058546A1 Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene
11/18/1999WO1999058544A1 Hybrid anthracyclines from genetically engineered streptomyces galilaeus strains
11/18/1999WO1999058474A1 Generation of combinatorial libraries of compounds corresponding to virtual libraries of compounds
11/18/1999WO1999058364A1 Twin frame seat assembly
11/18/1999WO1999058363A1 Vehicle seat assembly with thermoformed fibrous suspension panel
11/18/1999WO1999058157A1 Method for inhibiting antibody-mediated rejection of xenogeneic tissues
11/18/1999WO1999058156A1 Cancer prevention by selective delivery methods
11/18/1999WO1999058155A1 Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
11/18/1999WO1999058146A1 ATTENUATED MUTANTS OF SALMONELLA WHICH CONSTITUTIVELY EXPRESS THE Vi ANTIGEN
11/18/1999WO1999058143A1 Utilization of interferon alpha 5 in the treatment of viral hepatopathies
11/18/1999WO1999058137A1 Bio-pharmaceutical preparation containing a live culture of bacillus and method for treating viral and bacterial infections as well as immuno-deficiency conditions
11/18/1999WO1999058134A1 Methods and compositions for nucleic acid delivery
11/18/1999WO1999058118A2 METHODS FOR REGULATING HEMATOPOIESIS USING CpG-OLIGONUCLEOTIDES
11/18/1999WO1999058101A1 Use of metalloprotinease inhibitors for inducing and/or stimulating growth of hair or hairs and/or for slowing down their loss
11/18/1999WO1999058098A2 HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO
11/18/1999WO1999057992A1 Compositions and methods for protein purification based on a metal ion affinity site
11/18/1999WO1999053044A3 High throughput dna sequencing vector
11/18/1999WO1999051740A3 Nucleotide sequence expressing human fatty acid transport protein and corresponding aminoacid, use for the regulation of fatty acids metabolism
11/18/1999WO1999051728A3 Control of floral induction in plants and uses therefor
11/18/1999WO1999051636A3 Gaba b receptor
11/18/1999WO1999050422A3 Method for reduction of fusel oils in alcoholic beverages and food products
11/18/1999WO1999050419A3 A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts
11/18/1999WO1999050406A3 Growth differentiation factor-9 regulatory sequences and uses therefor
11/18/1999WO1999050285A3 Production methods and uses of a retrovirus
11/18/1999WO1999049888A3 Identification of bacterial avirulence genes and their products; vaccines and pharmaceutical compositions containing them
11/18/1999WO1999048915A9 Orphan nuclear receptor
11/18/1999WO1999047690A3 Multigene vectors
11/18/1999WO1999047683A9 Gene encoding labyrinthin, a marker for cancer
11/18/1999WO1999047673A3 Isolated mammalian membrane protein genes and related reagents
11/18/1999WO1999047652A3 Novel rnase-like protein and its use
11/18/1999WO1999047649A9 Polymerase chimeras
11/18/1999WO1999047643A9 Selection subtraction approach to gene identification
11/18/1999WO1999047557A3 Identification of factors which mediate the interaction of heterotrimeric g proteins and monomeric g proteins
11/18/1999WO1999047552A3 Genes encoding mlo proteins and conferring fungal resistance upon plants
11/18/1999WO1999046370A3 Expression of trehalose biosynthetic genes in plants
11/18/1999WO1999046364A9 Vascular endothelial growth factor 2
11/18/1999WO1999046297A9 Mutants of monoamine oxidase b
11/18/1999WO1999046284A9 Molecules that home to various selected organs or tissues
11/18/1999WO1999046283A9 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
11/18/1999WO1999046281A9 Novel polypeptides and nucleic acids encoding the same
11/18/1999WO1999045962A9 Transgenic non-human animals capable of producing heterologous antibodies
11/18/1999WO1999045124A3 Modified forms of pullulanase
11/18/1999WO1999043830A3 Human platelet heparanase polypeptides, polynucleotide molecules that encode them, and methods for the identification of compounds that alter heparanase activity
11/18/1999WO1999042584A9 Apoptosis inducing molecule ii and methods of use
11/18/1999WO1999042571A8 Method for screening compounds capable of inhibiting fixing between the transcription factor of stat1 and the transcription factor of usf1
11/18/1999WO1999042076A9 Compounds and methods for immunotherapy and diagnosis of tuberculosis
11/18/1999WO1999041416A3 Compositions comprising viruses and methods for concentrating virus preparations
11/18/1999WO1999038985A3 HIGHLY EFFICIENT CONTROLLED EXPRESSION OF EXOGENOUS GENES IN $i(E. COLI)
11/18/1999WO1999038981A3 Human protein kinase molecules
11/18/1999WO1999037803A9 INHIBITION OF DNA MODULATION CAUSED BY MUTATED p53
11/18/1999WO1999036550A3 Human protease molecules
11/18/1999WO1999034003A3 Proteases from gram positive organisms
11/18/1999WO1999033980A3 Members of tnf and tnfr families
11/18/1999WO1999028475A3 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/18/1999WO1999028349A3 CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS
11/18/1999WO1999027098A3 A-33 related antigens and their pharmacological uses
11/18/1999DE19826444C1 DNA encoding a spinach glucose translocator, plasmids, bacteria, yeast and transformed plant cells
11/18/1999DE19821925A1 Bacteriophage expression system for production of composition for induction of tumor specific responses
11/18/1999CA2685270A1 Expression vectors for stimulating an immune response and methods of using the same
11/18/1999CA2404693A1 97 human secreted proteins
11/18/1999CA2332109A1 97 human secreted proteins
11/18/1999CA2331853A1 Recombinant baculovirus-based insecticides
11/18/1999CA2331621A1 Methods for identifying pathways of drug action
11/18/1999CA2331510A1 Quantitative methods, systems and apparatuses for gene expression analysis
11/18/1999CA2331315A1 Identification of molecular interaction sites in rna for novel drug discovery
11/18/1999CA2331311A1 Nucleic acid molecules encoding wheat enzymes involved in startch synthesis
11/18/1999CA2331061A1 Complex formed by a peptide and a major histocompatibility complex at the surface of phages
11/18/1999CA2330741A1 Methods of forming protein-linked lipidic microparticles, and compositions thereof
11/18/1999CA2328606A1 Antibodies to cd23, derivatives thereof, and their therapeutic uses
11/18/1999CA2328589A1 Heteroduplex mutational vectors and use thereof in bacteria
11/18/1999CA2328521A1 Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
11/18/1999CA2328518A1 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
11/18/1999CA2328508A1 Nucleic acid molecules encoding wheat enzymes involved in starch synthesis
11/18/1999CA2328502A1 Cloning of basb020 antigen from moraxella catarrhalis
11/18/1999CA2328493A1 Transgenic plant-derived human blood coagulation factors
11/18/1999CA2328492A1 Human deadenylating nuclease, its preparation and use
11/18/1999CA2328490A1 Fused protein
11/18/1999CA2328481A1 Methods and compositions for screening for modulators of ige synthesis, secretion and switch rearrangement
11/18/1999CA2328477A1 Cell-free chimeraplasty and eukaryotic use of heteroduplex mutational vectors
11/18/1999CA2328429A1 Basb028 polypeptides and polynucleotides encoding therefor from moraxella catarrhalis
11/18/1999CA2328422A1 Selection system
11/18/1999CA2328406A1 Methods for regulating hematopoiesis using cpg-oligonucleotides
11/18/1999CA2328405A1 Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene
11/18/1999CA2328403A1 Basb029 polynucleotide(s) and polypeptides from neisseria meningitidis
11/18/1999CA2328397A1 Human antithrombin iiis and methods related thereto
11/18/1999CA2328141A1 Compounds from moraxella catarrhalis
11/18/1999CA2328131A1 Method for producing plants having an increased tolerance against drought and/or fungal attack and/or increased salt concentrations and/or extreme temperature by the expression ofplasmodesmata-localized proteins
11/18/1999CA2328130A1 Moraxella catarrhalis proteins
11/18/1999CA2328062A1 Secreted proteins and polynucleotides encoding them
11/18/1999CA2328061A1 Novel compounds
11/18/1999CA2327549A1 Peptides that induce t cell responses
11/18/1999CA2327548A1 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors
11/18/1999CA2327546A1 Transgenic plant cells expressing a recombinant plant e2f peptide
11/18/1999CA2327523A1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use
11/18/1999CA2327354A1 Human apoptosis associated proteins
11/18/1999CA2327351A1 Cell signaling proteins
11/18/1999CA2327265A1 Zea mays phosphate transporter genes and uses thereof
11/18/1999CA2326722A1 Method for the production of 1,3-propanediol by recombinant organisms comprising genes for vitamin b12 transport
11/18/1999CA2325804A1 Novel gene combinations that alter the quality and functionality of soybean oil
11/18/1999CA2288993A1 Bio-pharmaceutical preparation containing a live culture of bacillus and method for treating viral and bacterial infections as well as immuno-deficiency conditions
1 ... 3324 3325 3326 3327 3328 3329 3330 3331 3332 3333 3334 3335 3336 3337 3338 3339 3340 3341 3342 3343 3344 ... 4023